1. Home
  2. ANL vs KRO Comparison

ANL vs KRO Comparison

Compare ANL & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$10.20

Market Cap

731.6M

Sector

N/A

ML Signal

HOLD

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$6.89

Market Cap

760.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANL
KRO
Founded
2004
1916
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
731.6M
760.5M
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
ANL
KRO
Price
$10.20
$6.89
Analyst Decision
Strong Buy
Strong Sell
Analyst Count
1
2
Target Price
$20.00
$6.00
AVG Volume (30 Days)
129.2K
237.6K
Earning Date
04-10-2026
05-06-2026
Dividend Yield
N/A
2.79%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,859,400,000.00
Revenue This Year
$36.02
$6.75
Revenue Next Year
N/A
$8.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$4.08
52 Week High
$17.25
$7.89

Technical Indicators

Market Signals
Indicator
ANL
KRO
Relative Strength Index (RSI) 40.94 50.40
Support Level $6.92 $6.08
Resistance Level $12.59 $7.55
Average True Range (ATR) 1.15 0.28
MACD -0.11 -0.05
Stochastic Oscillator 26.07 44.02

Price Performance

Historical Comparison
ANL
KRO

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

Share on Social Networks: